Anaphylaxis:
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Chichester
John Wiley & Sons
2004
|
| Schriftenreihe: | Novartis Foundation symposium
257 |
| Schlagworte: | |
| Online-Zugang: | FRO01 UBG01 Volltext |
| Beschreibung: | "Symposium on Anaphylaxis, held at the Novartis Foundation, 25-27 February 2003; editors, Gregory Bock (organizer) and Jamie Goode."--Contents page Includes bibliographical references and indexes Anaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis. Anaphylaxis is the main acute killer of allergic individuals. Although anaphylaxis was discovered at the beginning of the 20th century, there are still many unresolved issues. These include non-IgE-mediated anap |
| Beschreibung: | 1 Online-Ressource (ix, 296 pages) |
| ISBN: | 0470861150 9780470861158 0470861142 9780470861141 0470861193 9780470861196 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV043384993 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160222s2004 |||| o||u| ||||||eng d | ||
| 020 | |a 0470861150 |c electronic bk. |9 0-470-86115-0 | ||
| 020 | |a 9780470861158 |c electronic bk. |9 978-0-470-86115-8 | ||
| 020 | |a 0470861142 |c alk. paper |9 0-470-86114-2 | ||
| 020 | |a 9780470861141 |c alk. paper |9 978-0-470-86114-1 | ||
| 020 | |a 0470861193 |c electronic bk. |9 0-470-86119-3 | ||
| 020 | |a 9780470861196 |c electronic bk. |9 978-0-470-86119-6 | ||
| 024 | 7 | |a 10.1002/0470861193 |2 doi | |
| 035 | |a (ZDB-35-WIC)ocm55143463 | ||
| 035 | |a (OCoLC)55143463 | ||
| 035 | |a (DE-599)BVBBV043384993 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-861 | ||
| 082 | 0 | |a 616.97 |2 22 | |
| 110 | 2 | |a Symposium on Anaphylaxis <2003, Novartis Foundation> |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Anaphylaxis |
| 264 | 1 | |a Chichester |b John Wiley & Sons |c 2004 | |
| 300 | |a 1 Online-Ressource (ix, 296 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Novartis Foundation symposium |v 257 | |
| 500 | |a "Symposium on Anaphylaxis, held at the Novartis Foundation, 25-27 February 2003; editors, Gregory Bock (organizer) and Jamie Goode."--Contents page | ||
| 500 | |a Includes bibliographical references and indexes | ||
| 500 | |a Anaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis. Anaphylaxis is the main acute killer of allergic individuals. Although anaphylaxis was discovered at the beginning of the 20th century, there are still many unresolved issues. These include non-IgE-mediated anap | ||
| 650 | 4 | |a Novartis | |
| 650 | 7 | |a MEDICAL / Immunology |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Allergies |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Immune System |2 bisacsh | |
| 650 | 4 | |a Anaphylaxis / Congresses / diagnosis | |
| 650 | 4 | |a Anaphylaxis / Congresses / therapy | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Anaphylaxis | |
| 650 | 4 | |a Anaphylaxis / Diagnosis | |
| 650 | 4 | |a Anaphylaxis / Treatment | |
| 650 | 0 | 7 | |a Anaphylaxie |0 (DE-588)4001886-6 |2 gnd |9 rswk-swf |
| 653 | |a Electronic books | ||
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Anaphylaxie |0 (DE-588)4001886-6 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Bock, Gregory |e Sonstige |4 oth | |
| 700 | 1 | |a Goode, Jamie |e Sonstige |4 oth | |
| 710 | 2 | |a Novartis Foundation |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/0470861193 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-35-WIC | ||
| 940 | 1 | |q UBG_PDA_WIC | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028803577 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/0470861193 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/0470861193 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175952794615808 |
|---|---|
| any_adam_object | |
| author_corporate | Symposium on Anaphylaxis <2003, Novartis Foundation> |
| author_corporate_role | aut |
| author_facet | Symposium on Anaphylaxis <2003, Novartis Foundation> |
| author_sort | Symposium on Anaphylaxis <2003, Novartis Foundation> |
| building | Verbundindex |
| bvnumber | BV043384993 |
| collection | ZDB-35-WIC |
| ctrlnum | (ZDB-35-WIC)ocm55143463 (OCoLC)55143463 (DE-599)BVBBV043384993 |
| dewey-full | 616.97 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.97 |
| dewey-search | 616.97 |
| dewey-sort | 3616.97 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03378nmm a2200685zcb4500</leader><controlfield tag="001">BV043384993</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2004 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470861150</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-86115-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470861158</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-86115-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470861142</subfield><subfield code="c">alk. paper</subfield><subfield code="9">0-470-86114-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470861141</subfield><subfield code="c">alk. paper</subfield><subfield code="9">978-0-470-86114-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470861193</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-86119-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470861196</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-86119-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/0470861193</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocm55143463</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)55143463</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043384993</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.97</subfield><subfield code="2">22</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Symposium on Anaphylaxis <2003, Novartis Foundation></subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anaphylaxis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester</subfield><subfield code="b">John Wiley & Sons</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (ix, 296 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Novartis Foundation symposium</subfield><subfield code="v">257</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Symposium on Anaphylaxis, held at the Novartis Foundation, 25-27 February 2003; editors, Gregory Bock (organizer) and Jamie Goode."--Contents page</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and indexes</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Anaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis. Anaphylaxis is the main acute killer of allergic individuals. Although anaphylaxis was discovered at the beginning of the 20th century, there are still many unresolved issues. These include non-IgE-mediated anap</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Novartis</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Immunology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Allergies</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Immune System</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaphylaxis / Congresses / diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaphylaxis / Congresses / therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaphylaxis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaphylaxis / Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaphylaxis / Treatment</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Anaphylaxie</subfield><subfield code="0">(DE-588)4001886-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Anaphylaxie</subfield><subfield code="0">(DE-588)4001886-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bock, Gregory</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goode, Jamie</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Novartis Foundation</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/0470861193</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028803577</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/0470861193</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/0470861193</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV043384993 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:24:28Z |
| institution | BVB |
| isbn | 0470861150 9780470861158 0470861142 9780470861141 0470861193 9780470861196 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028803577 |
| oclc_num | 55143463 |
| open_access_boolean | |
| owner | DE-861 |
| owner_facet | DE-861 |
| physical | 1 Online-Ressource (ix, 296 pages) |
| psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | John Wiley & Sons |
| record_format | marc |
| series2 | Novartis Foundation symposium |
| spelling | Symposium on Anaphylaxis <2003, Novartis Foundation> Verfasser aut Anaphylaxis Chichester John Wiley & Sons 2004 1 Online-Ressource (ix, 296 pages) txt rdacontent c rdamedia cr rdacarrier Novartis Foundation symposium 257 "Symposium on Anaphylaxis, held at the Novartis Foundation, 25-27 February 2003; editors, Gregory Bock (organizer) and Jamie Goode."--Contents page Includes bibliographical references and indexes Anaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis. Anaphylaxis is the main acute killer of allergic individuals. Although anaphylaxis was discovered at the beginning of the 20th century, there are still many unresolved issues. These include non-IgE-mediated anap Novartis MEDICAL / Immunology bisacsh HEALTH & FITNESS / Allergies bisacsh HEALTH & FITNESS / Diseases / Immune System bisacsh Anaphylaxis / Congresses / diagnosis Anaphylaxis / Congresses / therapy Medizin Anaphylaxis / Diagnosis Anaphylaxis / Treatment Anaphylaxie (DE-588)4001886-6 gnd rswk-swf Electronic books (DE-588)1071861417 Konferenzschrift gnd-content Anaphylaxie (DE-588)4001886-6 s 1\p DE-604 Bock, Gregory Sonstige oth Goode, Jamie Sonstige oth Novartis Foundation Sonstige oth https://onlinelibrary.wiley.com/doi/book/10.1002/0470861193 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Anaphylaxis Novartis MEDICAL / Immunology bisacsh HEALTH & FITNESS / Allergies bisacsh HEALTH & FITNESS / Diseases / Immune System bisacsh Anaphylaxis / Congresses / diagnosis Anaphylaxis / Congresses / therapy Medizin Anaphylaxis Anaphylaxis / Diagnosis Anaphylaxis / Treatment Anaphylaxie (DE-588)4001886-6 gnd |
| subject_GND | (DE-588)4001886-6 (DE-588)1071861417 |
| title | Anaphylaxis |
| title_auth | Anaphylaxis |
| title_exact_search | Anaphylaxis |
| title_full | Anaphylaxis |
| title_fullStr | Anaphylaxis |
| title_full_unstemmed | Anaphylaxis |
| title_short | Anaphylaxis |
| title_sort | anaphylaxis |
| topic | Novartis MEDICAL / Immunology bisacsh HEALTH & FITNESS / Allergies bisacsh HEALTH & FITNESS / Diseases / Immune System bisacsh Anaphylaxis / Congresses / diagnosis Anaphylaxis / Congresses / therapy Medizin Anaphylaxis Anaphylaxis / Diagnosis Anaphylaxis / Treatment Anaphylaxie (DE-588)4001886-6 gnd |
| topic_facet | Novartis MEDICAL / Immunology HEALTH & FITNESS / Allergies HEALTH & FITNESS / Diseases / Immune System Anaphylaxis / Congresses / diagnosis Anaphylaxis / Congresses / therapy Medizin Anaphylaxis Anaphylaxis / Diagnosis Anaphylaxis / Treatment Anaphylaxie Konferenzschrift |
| url | https://onlinelibrary.wiley.com/doi/book/10.1002/0470861193 |
| work_keys_str_mv | AT symposiumonanaphylaxis2003novartisfoundation anaphylaxis AT bockgregory anaphylaxis AT goodejamie anaphylaxis AT novartisfoundation anaphylaxis |